11th Annual Prevention and Therapies for Hepatitis and Chronic Liver Disease

Seminar Overview

This seminar series will provide updates on the diagnosis and treatment of the dominant forms of viral hepatitis and explore the latest data on advancing liver disease, hepatocellular carcinoma, cholestatic liver disease, MASLD/MASH and other hepatic conditions.

Location-specific faculty experts will deliver state-of-the-art material utilizing a curriculum that features lectures, case analysis, current clinical trial outcomes and progress reports on promising prevention approaches and emerging therapies.

The seminar will concentrate on key diseases of the liver and address the latest diagnosis, treatment, and care management approaches in a setting that stresses interactive learning, audience participation, and collaborative discussion.

The program will increase the number of clinicians educated in preventing, diagnosing, treating, and/or referring liver-disease patients for more advanced care. The goal of this CME activity is to limit future cases and improve the outcomes of those already infected.

The live seminars will be delivered in a hybrid format that uses both live lectures and several web-based pre-readings and post-program modules. In this way, participants can earn 8.5 Category 1 CME Credits™ while spending just one day in the classroom.

Available in two formats

A live, face-to-face seminar, supplemented by pre, and post program presentations

A web-based version of the 2025 activity is available now!







All activities are accredited for AMA PRA Category 1 Credit(s)TM

Upcoming Dates and Locations

March 7, 2026 - Louisville, KY - Click here to register.







March 14, 2026 - Dallas, TX - Click here to register.







March 28, 2026 - New York City, NY - Click here to register.








To Register for any Seminar: Click on the Date and City above and you will be taken to the registration site.





Registration Fees

    For Live Program

  • Physicians, Pharmacists and Administrators - $175

  • Nurses, NP’s and PA’s - $95

  • Residents and Fellows - $75


  • For Web-based Enduring Materials

  • Physicians, Pharmacists and Administrators - $135

  • Nurses, NP’s and PA’s - $75

  • Residents and Fellows - $60

Target Audience

  • Gastroenterologists
  • Internists
  • Hepatologists
  • Family Physicians
  • Endocrinologists
  • Advanced-Practice Providers and Nurse Specialists
  • Clinical Pharmacists


The Colorado Medical Society and the SC Liver Research Consortium wishes to acknowledge the contributions of the following organizations whose non-restricted educational grants have helped make this seminar series possible.
Gilead Sciences
Ipsen Biopharmaceuticals
Madrigal Pharmaceuticals
Mallinckrodt Pharmaceuticals/br> Mirum Pharmaceuticals
Novo Nordisk
Salix: A Division of Bausch Health

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Colorado Medical Society and SC Liver Research Consortium.

The Colorado Medical Society is accredited by the ACCME to provide continuing medical education for physicians.

For More Information on this seminar series, please contact Aubrey Shoe, Director of CME at SCLRC at shoe.aubrey@scliver.com or at (505) 453-5655

This seminar series is administered and accredited to provide education credit by:
Colorado Medical Society
Office of Continuing Medical Education
7351 Lowry Blvd, Suite 110
Denver, CO 80230

Phone - 720.739.8138

Email:cme@cms.org

Top